<SEC-DOCUMENT>0001140361-22-039934.txt : 20221104
<SEC-HEADER>0001140361-22-039934.hdr.sgml : 20221104
<ACCEPTANCE-DATETIME>20221104070523
ACCESSION NUMBER:		0001140361-22-039934
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221031
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221104
DATE AS OF CHANGE:		20221104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IONIS PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000874015
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330336973
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19125
		FILM NUMBER:		221360154

	BUSINESS ADDRESS:	
		STREET 1:		2855 GAZELLE COURT
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92010
		BUSINESS PHONE:		7609319200

	MAIL ADDRESS:	
		STREET 1:		2855 GAZELLE COURT
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ISIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10043749_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ions="http://ionispharma.com/20221031" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_01e560f1345d40fba67a31034b222d5b" contextRef="c20221031to20221031" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_f3ed2dd34fe54c06ad2f43805391a9f8" contextRef="c20221031to20221031">0000874015</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ions-20221031.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20221031to20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874015</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-31</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C.&#160; 20549</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_790431b79ccc47fea740d159fc445680" contextRef="c20221031to20221031">8-K</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;PURSUANT TO SECTION 13 OR 15(d) OF THE</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;SECURITIES EXCHANGE ACT OF 1934</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_47a3f15131ba4fac910ebdb6c55dd91f" contextRef="c20221031to20221031" format="ixt:date-monthname-day-year-en">October 31, 2022</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_c43555badf0f4e20881bd9385862ce9c" contextRef="c20221031to20221031">IONIS PHARMACEUTICALS, INC.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact Name of Registrant as Specified in Charter)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_4f88943a0af1451cbba0a92f7e9d9367" contextRef="c20221031to20221031" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(State or Other Jurisdiction of Incorporation)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_2cc4a9dc8fea4690910a3f596d4ee0f7" contextRef="c20221031to20221031">000-19125</ix:nonNumeric><br />
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_89dfd0513734463ba9a4279faaa6665c" contextRef="c20221031to20221031">33-0336973</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(Commission File No.)</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_be5f9465d77a435b916c3523d1debc0e" contextRef="c20221031to20221031">2855 Gazelle Court</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_4213a772edbb4560aceeb756dd026a12" contextRef="c20221031to20221031">Carlsbad</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_fb93b2adf4b340e7a4c61b1c6d9f5596" contextRef="c20221031to20221031">CA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_da505f5509b64be2b3e03832efaef66f" contextRef="c20221031to20221031">92010</ix:nonNumeric></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Address of Principal Executive Offices and Zip Code)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_59bc6e9f18174394b19040d4d4e4842c" contextRef="c20221031to20221031">760</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_b86d1417f95a49de83a85a49858efa80" contextRef="c20221031to20221031">931-9200</ix:nonNumeric></span></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" />
<div><br /></div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <div>
          <div>
            <div>
              <div>
                <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_2afe8610d52e48b7bb9e0dcd8699af8f" contextRef="c20221031to20221031" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="text-align: justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                      </td>

  </tr>


</table>
              </div>

            </div>

          </div>

        </div>

      </div>

      <div style="text-align: left; text-indent: -27pt; margin-left: 45pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_4666e54c0a154c6697edecf3d90084ab" contextRef="c20221031to20221031" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: auto; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: -27pt; margin-left: 45pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_df8d8a703f59473f98845cbe45a4ec88" contextRef="c20221031to20221031" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: auto; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: -27pt; margin-left: 45pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_7d8f91dc0d894fedbd62f9fb3e11844a" contextRef="c20221031to20221031" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: auto; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Title of each class</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Trading symbol</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_585c20a6736044a4b0e959d3d7c3ce51" contextRef="c20221031to20221031">Common Stock, $.001 Par Value</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 25%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">&#8220;<ix:nonNumeric name="dei:TradingSymbol" id="Fact_fb402b1fa5a44b36b1228583b6337863" contextRef="c20221031to20221031">IONS</ix:nonNumeric>&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 36%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_e4b4eff21c7740b4b094c9d33f090723" contextRef="c20221031to20221031" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or
        Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 92%; text-align: right;">Emerging growth company</td>

    <td style="width: 8%; text-align: right;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_c8f29498c1894557b6d05ef4f9fd8e61" contextRef="c20221031to20221031" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </td>

  </tr>


</table>
        <div> <br />
        </div>

      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.<span style="color: rgb(0, 0, 0);"> &#160; &#9744;</span></div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> <br />
        </span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                  <div style="font-weight: bold;">Item 1.02</div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="font-weight: bold;">Termination of a Material Definitive Agreement.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On November 4, 2022, Ionis Pharmaceuticals, Inc. (the &#8220;<span style="font-weight: bold; font-style: italic;">Company</span>&#8221;) issued a press release announcing that
        while fesomersen, an investigational antisense therapy that is being evaluated to reduce the production of Factor XI for the prevention of thrombosis, achieved its primary endpoint&#160; in the Phase 2b RE-THINC ESRD study, the Company&#8217;s partner, Bayer
        AG (&#8220;<span style="font-weight: bold; font-style: italic;">Bayer</span>&#8221;), is discontinuing the Bayer-led clinical development program for fesomersen and will return development and commercialization rights to fesomersen to the Company.</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">A copy of this press release is attached as Exhibit 99.1 to this Current Report and incorporated herein by reference.</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company entered into a License Agreement with Bayer for the development and commercialization of fesomersen on May 1, 2015 (the &#8220;<span style="font-weight: bold; font-style: italic;">License Agreement</span>&#8221;), as amended on February 10, 2017 (&#8220;<span style="font-weight: bold; font-style: italic;">Amendment #1</span>&#8221;) (collectively, the &#8220;<span style="font-weight: bold; font-style: italic;">Agreement</span>&#8221;).


        Under the terms of the Agreement, the Company granted Bayer an exclusive license, with the right to grant certain sublicenses, to research, develop, manufacture and commercialize fesomersen worldwide. The Agreement will terminate effective January
        29, 2023.</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Agreement is a summary only and is qualified in its entirety by reference to the terms of the License Agreement and Amendment #1,
        copies of each of which were filed as Exhibit 10.50 and 10.11, respectively, to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</div>

      <div><br />
      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                  <div style="font-weight: bold;">Item 9.01.</div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div><br />
      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div>(d)</div>
                </td>

    <td style="vertical-align: top; width: auto;">
                  <div>Exhibits.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><span style="text-decoration: underline;">Exhibit No.</span></div>
            </td>

    <td style="width: 88%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;"><span style="text-decoration: underline;">Description</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10043749_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Press Release dated November 4, 2022.</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 12%; vertical-align: top;"><br />
            </td>

    <td rowspan="1" style="width: 88%; vertical-align: top;"><br />
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 12%; vertical-align: top; text-align: center;">104</td>

    <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;Cover Page Interactive Data File (embedded within the Inline XBRL document).</td>

  </tr>


</table>
      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-variant: small-caps; font-weight: bold;">SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
        behalf by the undersigned, thereunto duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; font-variant: small-caps; font-weight: bold;">Ionis Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td rowspan="1" colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: justify;">Dated:&#160; November 4, 2022</div>
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: justify;">By:</div>
            </td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify;">/s/ Patrick R. O&#8217;Neil</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; font-variant: small-caps; font-weight: bold;">Patrick R. O&#8217;Neil</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Executive Vice President, Chief Legal</div>
              <div style="text-align: justify;">Officer and General Counsel</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10043749_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--><font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 99.1</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><img width="209" height="68" src="image01.jpg"></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis announces positive results from fesomersen development program</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z4a6b3b08271f419d91cf1bd90c4bdcc8" class="DSPFListTable">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">
                    <div><br>
                    </div>
                  </td>
                  <td style="vertical-align: top; width: 18pt;">
                    <div style="text-align: left; color: rgb(34, 31, 31); font-style: italic;"><font style="text-align: left; color: rgb(34, 31, 31); font-style: italic;">&#8722;</font></div>
                  </td>
                  <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; color: rgb(34, 31, 31); font-style: italic;">Positive Phase 2b data from RE-THINC ESRD study of fesomersen in patients on hemodialysis presented at Kidney Week 2022</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z9aacdee6198240d58ef6f6a82afc94a7" class="DSPFListTable">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">
                    <div><br>
                    </div>
                  </td>
                  <td style="vertical-align: top; width: 18pt;">
                    <div style="text-align: left; font-style: italic;"><font style="text-align: left; font-style: italic;">&#8722;</font></div>
                  </td>
                  <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; font-style: italic;">Ionis to regain rights to fesomersen from Bayer</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">CARLSBAD, Calif., November 4, 2022</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> &#8211; Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the Phase 2b RE-THINC ESRD study of fesomersen (formerly IONIS-FXI-L<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">Rx</sub>), an investigational antisense medicine designed to reduce the
          production of Factor XI (FXI) for the prevention of thrombosis, were presented by Bayer at the American Society of Nephrology&#8217;s (ASN) Kidney Week 2022. The RE-THINC ESRD study evaluated fesomersen in patients with end-stage renal disease (ESRD)
          on hemodialysis.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the study, fesomersen achieved its primary endpoint, demonstrating no increase in the incidence of the composite of major bleeding and clinically relevant non-major
        (CRNM) bleeding with 24 weeks of treatment.&#160;Fesomersen also achieved dose-dependent and sustained median reductions in steady-state FXI levels of 53.1%, 72.2% and 86.6% in the 40 mg, 80 mg, and 120 mg doses of fesomersen, respectively, administered
        once every 4 weeks. statistically significant. Incidences of dialysis circuit clotting and AV-access thrombosis diminished significantly with decreasing FXI levels, both of which were exploratory efficacy endpoints. Fesomersen showed favorable
        safety and tolerability with 48 weeks of treatment in this study.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We are very pleased with the efficacy and safety data seen in the Phase 2b study of fesomersen in patients with ESRD, which we believe supports continued advancement of
        this potential novel anti-thrombotic therapy for patients with renal and cardiovascular diseases,&#8221; said Richard S. Geary, Ph.D., executive vice president and chief development officer at Ionis. &#8220;We thank Bayer for their partnership in the
        development of fesomersen. We are focused on getting fesomersen into the hands of a new partner to deliver it to the market and patients in need.&#8221;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About the RE-THINC ESRD Study</div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">RE-THINC <font style="color: rgb(0, 0, 0);">ESRD (</font><u>NCT04534114</u><font style="color: rgb(0, 0, 0);">) is a </font>randomized, double-blind,
          placebo-controlled study evaluating the safety, pharmacokinetics and pharmacodynamics of multiple doses of fesomersen in 307 patients with end-stage renal disease on hemodialysis. Study participants were randomized to each of 3 dose cohorts or
          placebo administered subcutaneously every four weeks for up to 48 weeks.&#160;The RE-THINC ESRD study was conducted by Bayer, which licensed fesomersen from Ionis.<font style="color: rgb(55, 55, 55);">&#160;&#160;</font></div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Thrombosis</div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Thrombosis is the formation of blood clots inside blood vessels. Blood clots can obstruct blood flow to prevent sufficient oxygen flow to tissues and organs. In
          addition, clot fragments can break off from the blood clot and travel to occlude other parts of the circulation. Thrombosis is responsible for many heart attacks and strokes and is the leading cause of morbidity and mortality worldwide. Current
          anti-thrombotic treatments include anticoagulants such as warfarin, Factor Xa inhibitors and thrombin inhibitors. Although these therapies are effective at lowering the risk of thrombosis, they can place patients at significant risk of bleeding
          because they target factors required for normal coagulation.</div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Fesomersen</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Fesomersen, (formerly IONIS-FXI-L<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">Rx</sub>) is an investigational antisense medicine designed by Ionis
          to reduce the production of Factor XI, a clotting factor produced in the liver that is an important component of the coagulation pathway. High levels of Factor XI increase the risk of blood clot formation inside blood vessels (thrombosis), which
          can cause heart attacks and strokes. Alternatively, individuals deficient in Factor XI have a lower incidence of thrombosis-related events and little to no increase in bleeding risk. This makes Factor XI an attractive target for an
          anti-thrombotic medicine because of the potential to separate anti-thrombotic activity from bleeding risk. Although currently available anticoagulants reduce the risk of thrombosis, these anticoagulants are associated with increased bleeding risk
          at therapeutic doses, which can lead to major, sometimes fatal, bleeding events.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br>
        </div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Ionis Pharmaceuticals, Inc.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology.
        Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on
        us, which fuels our vision of becoming a leading, fully integrated biotechnology company.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">To learn more about Ionis, visit <u>www.ionispharma.com</u><font style="color: rgb(0, 0, 0);"> an</font>d follow us on Twitter @ionispharma.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis&#8217; Forward-looking Statements</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This press release includes forward-looking statements regarding Ionis&#8217; business and the therapeutic and commercial potential of Ionis&#8217; technologies, fesomersen and other
        products in development. Any statement describing Ionis&#8217; goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Such statements are subject to certain risks and uncertainties, including those related to the impact COVID-19 could have on our business, and
        including but not limited to, those related to our commercial products and the medicines in our pipeline, and particularly those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as
        human therapeutics, and in the endeavor of building a business around such medicines. Ionis&#8217; forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from
        those expressed or implied by such forward-looking statements.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Although Ionis&#8217; forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by
        Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis&#8217; programs are described in additional detail in Ionis&#8217; annual report on Form 10-K for the year ended December 31, 2021,
        and the most recent Form 10-Q quarterly filing, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In this press release, unless the context requires otherwise, &#8220;Ionis,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; refers to Ionis Pharmaceuticals and its subsidiaries.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ionis Pharmaceuticals&#174; is a trademark of Ionis Pharmaceuticals, Inc.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis Pharmaceuticals Investor Contact:</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">760-603-2331</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis Pharmaceuticals Media Contact:</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">760-603-4679</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"># # #</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;"> <br>
        </font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">3</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ions-20221031.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<xs:schema targetNamespace="http://ionispharma.com/20221031" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:ions="http://ionispharma.com/20221031" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ions-20221031_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ions-20221031_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://ionispharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ions-20221031_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ions-20221031_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://ionispharma.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="ions-20221031.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://ionispharma.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0N!WH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,UC:W?QVUNVX]JOW5P+>-F
M)Z"O)O&OBA6#1(_/(K2$=;G9A:#G*YL^'[^.^OY!&<X:O1X>(5^E>*?"_>]Y
M.[DD$YKVV/\ U:_2G5W#&*TK#J***R.,**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD- "TC'"DTM9
M6L7Z6EJ[;@"!32NRX0<Y61S'C37UL82H;J,5X1J]ZU[=[MQ/S5O>+O$#:A=-
M'NR%:N3_ .6B^YKLA"R/J,'AE"&IZW\,$Y:O9(_N"O)?AC%@,:];3[HKFJ[G
MB9C_ !1:***S//"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5BAQU45U=9'A^'RM,@X_@%:]>?4=V?$8F?/4;"BBBH, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IC/A2?2G
MUD:S?I:6KL6 .*:5RZ<')V1S?B_Q"+*W9 W4$=:\(U&[:ZNY&+$Y-;OB;7WO
M[J1-Q(#&N70;F)-=M.&A]5@<(H*X[.!3=U2%<TP+6C=CV%M81OD7-='X)L/M
MU^&QG:PKFG.X8KTSX1V/FW$I9>E34=HW/-S"IR4FSVK3X_+L8E]%%6::B[4"
M^E.KSSXUN["BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !11378*I)[4 0W5PL,9+''%>0?$#Q*R#RX7SDX.#76
M>+=?2W@95?!QZUX;J=_)?W3[SD \5M3B>[EN$O[S*4K&5_,/5CFE(V@8IP Q
M3,Y-=JT1]13@DK"$FD8^E.8C%,'O2%)ZB(I:=%]37N_PVTW['#OVXW 5XKIE
MN;B^A &<,*^E/#5HMOIT.!@E16%5Z'@9M5M#E-VBBBN0^:"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !378*I)-.K \0ZHME!D-CBFE<TI4
MW4DHHQ?%_B$65NR!NHQUKPG47-W>22$YR<UT?BS6VO'*[LX-<HKDFNF"2/KL
MOP:IJ[$V]J'7-/ICGTK<]:V@A&<4/TIN30IW4["6C&]:M:;;&YO(P!GYA55^
M.G>NX\ :,;RY+.G0YJ*C]TX<94Y(7/6O".F_9;*-L8RHKJQ56Q@$%LBCL*M5
MPR=V?%UIN<VPHHHI&04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%-=MJYH @NKE+>)F<XXKQWQQX@+L4C?//K77>--<6"W
M*QM@UXAJ%Y+=W+ECD9KHIPZGOY9A/MLC>4W#$M417;2("#3I.0,5NU9GU,$D
MK#>U"<YS2KQUIK<=*:U&UH( ,FFCY<TIR>E1R9) %4V9RE9$]I ]S=(H&1NK
MWWP5HB6=JK[0"RBO+_!FC-=7"L5S@@U[UIUL(+6-0,8%<U670^;S3$_91<3@
M8I](*6N8^>84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% "$XK%UK5DLK=MQ R*TKR80PLQ/05X]XN\1_:'>)7^Z<5I&-
M]3NP6&]M,Y_Q1K1NIV ?(S7+#J2>].E9IY6).>:9CM75!'VF'H*$+ "!2#K1
MC--'I5NS9LG9@U&X8IW:HB.::0VQ00N<U)86YNKE5 [U7;+NJCN:]#\&>&&N
M)%D*^AK.<K'GXRO[.+9W/@;1/LL(=UZ@5Z H &!5/3[5;:W1 ,8%7,@5QR=V
M?&XBJZD^9BT445)@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBD)H :QK(UG5$L;=B2.E7;RY%O$6)[5Y)XP\2
M^:S1*W0XK2*N=^#PKK378YGQ9JSWUPP5S]ZN<13C)J63,DA<G.:0\"MHJQ]M
MAZ*A!(C4$DTHY.*%;:32_=.?6M+G5LAAZTYAE::WK1YG:AD-D?K3K6W:ZF"+
MZTTG# >M=SX/\.FXF$A7WZ4F[(X<775.+.I\"^'O(_>.G45Z?"@1 H&,52TN
MR6UMU7;CBK<L@BC9B>@KFG*[/C,36=695U*^6SA9B>U>(^-M<;4IMD3_ '3S
MBNL\8^)0JM$&]17D[R,;AW8YW&J@M#WLIP-K3D0E6QDUTWA%5>\7CH17/.W'
MUKK_  %:&:[+8Z&KGL>QF%HT=#W*Q'^A1?[M6Q4%L-EM&OH*GKG/@);A1112
M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<6?'S#GWK%Q=SSYX><6=%15:&X5Q]X58# ]ZEJQSN+3%HHHI""BBB@ HHHH
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MSU,+%GL&D^-GDV@O79:;XC6<J"XY]Z^>(+UX'&TGBMJS\23PN,,:ETDSSZN
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M]:]VA_U2_2N&MN?(9I_%'T445B>8%%%% !1110 4444 %%%% !1110 4444
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MCZ[*E^[%(I5&30:0<5T-7/48I'S4F.:4TG:D,,<T8YH[4O:@!,<T8YH[4=J
M#'- '-+VI!0)B@?-3QR<4S-*,]:5M0L!'-1-]X>QIY)II%4R9I-'JGPZUG9.
MD+-P!7M4$@DB# YS7ROH&I/8WJL#CFOHSPQJ:7FEP_-EB*X:R/E\SHVES'0T
M4"BN<\<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!!UIL@RA^E/
MIK_</TH".YX[\21^[_&O-E&5 KTGXF\1#']ZO-8S\@KHB?>Y4_W*'8I1Z4TY
MI>U:'J1V% YHXH/2D2-YI55!GGFAK0B;Y8W+^F6#WERJ[21FO</"NB+96R/M
MP2*Y?P?X?4HDDB<XSTKTZWB$,2J.PK"3/C\UQ;E+D1+PJUSOB#5EM8&PW:M7
M4;M;>%B3CBO(_$VLO-*R*V1FN:<[(XL!A75G=F%J]^U]<OD]#621NXJ63.=W
MK2' 7-8(^SP])0BB,J *C89%)(QSQ02=M=$#IMJ1*-Q(/:HSUQ3WRO2F+WKL
MAL:6T#/%:OA[36O;Q<J<!JS;>%YYE51GFO6_!>@*JAW7G&>E*3U/)S#%*E!G
M:Z#8+9V<>!CY:V:B1/+C51VJ0=*YV?$59N<N9BT444&84444 %%%% !7->+A
MG3Y/]TUTM<SXNS_9\G^Z:NG\1TX3^,CYGN1_Q,9_]XTP"GWG&H3X_O&F5Z$%
MH?:4?A%ZTG6BBKL;7%ZTG6BBBP7%ZTG6BBBP7#K1BBBBP7"CK10>*3! *"/E
M-%(3\IIO8E['I'PM&7;_ 'J]WA_U2_2O!_A>2)&Q_>KWB'_4K]*\^MN?(YG_
M !!]%%%8GF!1110 4444 %%%% !1110 4444 %%%,=@H)/04 1W,Z0Q,S'&!
M7DOCKQ882T$;Y##'%=)XRU];2WD5'YVUX3J&HR:C.S2$G!KHI0ZGLY?A.9\S
M*D\AN9"['O2!1BFD8Z4N>*[$M#Z6$4E83MBE5>])WH)P:IEM=1^ PS3,4;B.
M*4T#0VE XI*6@ I1ZTE%.X(7WH]Z3FC-%QBT4G-%*X7"C%%% !VHQ10* "EI
M#11N&PM%)10%PHQ110(,4O:DHS1L O:DQQ1FBC<!*4#)HHZ&A@##!IP4;<TW
MK2@GI2L*PA.33MH*9III<G&*:!HC,>[BMS0]<DTJ9 I(P:QQUI&'S;JSG"YA
M6I*:L?07A7Q.+Z!-[\GWKN89TD4$,#7S!H6O365RB!B%!]:]D\,^)$N @>3K
M[UR5*=CYO%X)QNT>@T57BF6;#*<BK%8M'E-6"JM^F^V8>U6J:Z[E(-) G9GD
MK2&U\7J#PH->DF83:=N4YXKSOQC:O:W[W48Z=ZZ+PEJR7>D+'(WSGM6SV.VH
MDX*2.8A@?_A.5DVG&:]2:(36^TCM6!%I*?VN+C%=*HQQ42=S&K*[1Y#K=H^G
M^)C<HIX->D>'[PW.E+*YYQ5'7M'2YW2[<FHHKE-,T?83@BJ>J-)OVD4NIS7B
M2?[9K#VH.0:S/^$<_P!C]*FL ^H^+!)U0GK7HXTN/ X%-.QTJLJ:46?*QH-%
M%>@CZX#0:** "@T44 %!HHH *4TE% A>]*U-HH![CJ8]+2-TH02U1U_@;/VV
M/_>%?1MI_P >L?\ NBOG3P+Q>I_O"OHNT_X]8_\ =%<.(>I\MG#]]$U%%%<Y
MXP4444 %%%% !1110 4444 %%%% !1110 4444 %!XI,U2U&]6SMWD8]!FFE
M=CC%MV1F>(-8BL;=PS8./6O"?%.OR75V0CY7ZUN>-O$WVR9EB?MCBO."7D8E
MCDYKKITSZ3+\)978\D/R:08#4@!'%!&*Z5HCVXJRL.?&>*!C%-HI]"K >M!I
M1TI*2&Q5ZTKXSQ3>E!IB%[TAHHH&"]:<V,\4V@TO,0=Z.]%%,8=Z#110 G>E
M-&**$(*.]%% "TAH[44#84&BB@0"CO110 =Z.]%% Q<\TM-I>U'0$"_>IS8W
M4RBCH)BG&:08S111T%8",-D5J:9JLUI.NUB *SOX<4SGM4N-T95::E&Q]">"
M_$<=S91QN^7/O7<HV_D=*^9_"VM2:??Q[W(4&O?/#^LQZA:HRD'-<52'*?+8
MW".D[HWZ6FGD4J]*P/-%HHHH$%%%% !1110 4444 %%%% !1110 4444 %(>
ME+2'I0!Y-\3_ /CQEKQB,_+7M'Q0_P"0?)]:\53[M=]'X3Z[*M*8_O2=Z.U%
M;GJAWH[T44 '>E[TE% !WH[T44 '>E'6DI: #O3E(S3:09H87%.-U*N,TTT
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M-(S,<Y-7M5O7O;IR&R,UEOQ7GRJ<TC[#+\,J<+B$BHC3CDT,/EK6+T/3N1*
M2<TC8% ZTC?-TKIBM#1(8 #FH#PV/6I"VVK6FZ>^HW*A!G!KI@[(SK5%"%SH
M_".B-<3AV7(S7M.EV26T"@#!Q6%X5T9;2W0LG.*ZSA%^E14D?$YCBG5G9"G
MI16;<7ZI(%SWJ_$V^,'UKG4[O0\UQ:1)1116I(4444 %%%% !7->+<?V=)G^
MZ:Z6N8\7@G3Y/]TUI3^(Z<)_%1\U71']HW'^\:CIUT"=0G_WC3*]".Q]I0^$
M!0***HV 4444 %%%%  ***,4" 4&BC%  *1ONFEI&'!HZ ]CTCX6XWMGUKW>
M+_5+]*\'^%XR[8]:]XA_U2_2O/K;GR&9_P 0?1116)Y@4444 %%%% !1110
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MO!_A<-SM]:]XA_U2_2O/K_$?(9G_ !!]%%%8GF!1110 4444 %%%% !1110
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MYYIO>CO0.P9R:*.]%,044=Z*!A11WHH **** "BBB@ HHHH **.]% !1110
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M4M% [!11VH[4P"D-+GBDS0 44=J,T@"BCM1F@ HH[49H **.U':C8 P<4"G
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MQEJS7M\?FS@XKV#QSJHM;*6/=@E37SY<S-<3NS<\UU4(V/>RNA]ID*^GK3R
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M[II::W0T;(3V/2?A: 7;/K7N\7^J7Z5X/\,,[VQZU[Q#_J5^E>?6^(^0S/\
MB#Z***Q/,"BBB@ HHHH **** "J6IN([&1_05=K#\33^5I%P<_PFJBKLNFKR
M2/ _'%[]JU#KG!KF%'RU8U6X:XO9"3G#&JJGBO0@M#[7"1M3%HI#15^9V>0X
M#BFTII*9-K,<H!6FT9(HI+0 Q1VHHIC#%':BB@ Q1VHHH *2EHP:!#T (I2
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MZ[HOA2W2-2\8S]*YY3/-Q6,C&.APNC^$_-"L\?Z5VNG>#X,#*#\JZZ#2(80
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MU79'GXZI[.G<],T'2DL+5548XK=IB(%4 =J?7#*5V?(5)N;NPHHHJ2 HHHH
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ME8%88CX3Q\W?[HZ\&EI%&*6N$^6"BBD% "T444 %%%% !1110 4444 %%%%
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MM:7"R#UKWOP)K8N[:*-FZ+7!5CU/G<SP[?O(] HI <C(I:YSP HHHH ****
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M,W<G^\:^D/&;8TZ8?[)KYOO#B[D_WJ[:&Q]'E<;1N1XXHH[49KIV/?#%%%%
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M'WENUK<E&&.:^J]3M%N;5D89R*\"\<Z&]M?22JN%'M751F>_EN(TY6<4>M*
M-U1J>*=SUKLO<^BB[H<V-U)WI.M**12$-(.M.--H;"VHO>CO113$'>CO110,
M.]'>BB@ [TY0"U-H% AQ^_BM7PK<"UUZ.3.,&L@Y-/M9&ANE8=<U%171S5XW
M@T?5.@7/VG3$DSG(K5KD/ -SYWAZ')YQ77#I7G26I\76C:;%HHHJ3(**** "
MBBB@ I#TI:0]* /*/B?_ ,@^2O%(^E>U?%#_ )!\E>*1_=KOH;'UV5_PR2D[
MT=J*W/5#O1WHHH$'>CO110 =Z.]%% !WH[T44 '>CO110 4=Z**!A1WHHH .
M]+244!<4]*5,$TPY-'(H>PKW8K=:2CK2D<4@L%%':EQD4[CL+M!'TKL_ 6MM
M;:EL9L*.*XL'G%2VERUI<JZ''-93C=')BJ2G3/J_3KE;BT1P<Y%7*X;P3K N
M[&&,ME@M=P.17!*-F?'5Z?LYV%HHHJ3 **** "BBB@ IK\J:=36^Z:F6PUN>
M>^,,;.?6N.MH#-)@#-==XV#; %[FJ?AK2V=PSKP:^:KT'.N?18>LJ=$W?#FD
M!,,R]J[",;%QZ5%9VZPQ* .U+=SK;QDDU[-*FJ,#QJ]5UIE+5KY8(3\W.*\O
MU*\:]N75SP#Q6WKVJF5V5&[UR[Y+9'4UX>/Q?,[(]K 8907,PQCBG+@T'[M,
M .>*\4]GH*>M*,4E'-(;V% '-)'\SXIC$]!5ZPL9+B5=H[UO0IN<K&%>:A&Y
MN:!I7GRAF7BO1+2 0Q*H["L[1K%8+=..<5KDA%SZ5]9@<-R1N?*XJNZDB"\N
M$@B+,<<5Y]J7B0_;ECB?^+'!J]XSU](+=E1\''K7DVCZA)>:S\[9&^O7C#W;
MFE+#-TN=GT9ITAEL8G/4K5JJ6D_\@V'_ '15VLCSWN%%%% @HHHH **** "B
MBB@ KFO%P']G2?[IKI:YCQ?G^SY/]TU=/XCIPG\5'S3<@?VA/_O&F4MUG^T9
M_P#>-(:]&.Q]I0^ 044451L HHHH$ HHHH !1110 4444 %!^Z:2@_=H#H>D
M?"T NV?6O=XO]4OTKP?X89\QL>M>\0_ZE?I7GUOB/D,S_B#Z***Q/,"BBB@
MHHHH **** .2\:#_ (EDQ_V37S=<<W4F?[U?2?C)2=,F/^R:^;;OB[D_WJ[*
M&Q]+E;]Q(CH[4E+74>Z@[4444#%I.U!HH .U I*6@!>U)0:* "BDI:!"4X=*
M;2\TF . 8S7I?PQU46B+ 6QN:O,SFM;P_J#6>I0D-A0W-958\R.#&TO:0L?5
M$,@DC!![5)7->&]9CN[51NR?K72CI7!)6=CY"K3=.3BPHHHI&84444 %%%%
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M\CF%;GJ6706BBBLCS@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNG\1TX3^*CYGNCC49_\ >--I]R =1G_WC3*]&.Q]I0^ 3-%&*!5&P9HHQ0*
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MQU%%%(D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:2PYS7BVDQ>=JD*^K5]'^#K/[-IP&,9K"O+0\+-:EH6.G'2EHHKA/F0HHHH
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M:]WA_P!4OTKP?X7G#MCUKWB'_5+]*\^M\1\AF?\ $'T445B>8%%%% !1110
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M[7"U8^2E&SL%-;[IIU(WW34RV!'G?C+[OXUQ\6,<UU_C/[OXUQR\ 5\9F/\
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M\1TX3^*CYIN<?VC/_O&F4MT#_:,_^\:::]&.Q]I0^ !1115&P"BBB@ HHHH
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MS11B@ -&:*,4 !HS11B@ )HHQ10A"]:2EZ4E V%(W-+2-Q0Q/8[#P.<WL?\
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M0[T48HQ3 .]%&*,4 &:*,48H ,TY3@TW%*HR<4"!N31CC-!&#2J=W%#$-)'
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M8NRY6>:]33J3&QBI[4M==[GT,)WV#O2FD%*>*$:C:6@44T 449I>U "444M
M"44M% 6$HI:2@ HH[44 %%%% !0**6@!#1DXI>U)0#$I:*6@5A.]!I:3M0,*
M!2]J3M3>@ >M&3BCM1VI( H!-':CM0P%([TF3TIX(VU'28AW.*.2*4$;,4#&
MRDMP(BI!W"ND\,:]-9WL:%R$SZU@\;<5&K&)MR\&E)7.>M14XGTSX?UN*[ME
M 8%C[UTR'*YKY\\&^(FM;B,2/P#7NND7Z7]HLJ'(-<56'*?*8V@Z<C1HI,\X
MI:Q. **** "BBB@ HHHH **** "BBB@#X^Q1031FO6/T(,4449H ,4449H ,
M4449H ,449S10@%I*7K24##%(W2ES2-S0)['8>!AB]3_ 'A7T9:?\>L?^[7S
MGX&.;U/]X5]&6G_'K'_NUPXC<^4S;XT34445SGD!1110 4444 0W/_'NWTKP
M7XE#_3A7O5S_ ,>[?2O!/B4W^GK710W/7ROXF>?XQ2TF<T9KN/JH[!BEI*,T
M%"@449XI.M(84=:#0.M,EAC%%*QS2"A"044$T9H;*T#'.*MZ7\NK0_[U51US
M4]BV-3B;T-1+8QK_  ,^E?"!SIP^E=)7)^!I?-TS-=97G3^(^(Q'\1A1114F
M(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4&BB@"AJAVV3GVKYR\;MOUQ_K7T3KC;=.D/M7S?XN?.M.?>NK#GNY.M
MS#"XXII'-.#9YI"<G-=:N?3"8HQ1FC-/R$&*,49HS1Y &*,49HS1Y &*,49H
MS1Y &*7VI,T9H&(16UX0&=>C'O6-U-;7A [=>C/O42^$Y,7_  V?2FAC;IR#
MVK3K,T-MVGH?:M.O-EN?%5/B84444B HHHH *0]*6D/2@#R?XH?\@^2O%8Q\
MN*]J^*'_ "#Y*\5C/RYKOH;'UV5_PQ_M28H]Z,UN>J%%&:,T""BC-&: "BC-
M&: "C&31FE!YH!B8YH]J,\T>]2-#6'SI]:^E? 7_ "+EL/\ 9%?-3'YT/O7T
MKX"_Y%VV/^R*PKGS^;['7"JU[;K/ RL,\59%(>17&G9GSJ=G<^<O'&A-::C-
M<!< M7%XS7O7Q!TGS[)F"\YKPRYC-O<,GH:[J<KH^LP%92II$/2C/%!YI=O&
M:V/4N*$R*3'-.#X%-SSFFAB4"BC.*8!1BC-+28Q*,49HS1Y"#%+29HS0,**,
MT9H$%.6/?3<T^-]I- /8OZ%>M97R_-CFOH_PSJ(NM.A&<G;7R[O*S!QZUZ_\
M//$7F.L!;[HQUKDK0/"S'#<Z<CV+O5'4;U;2!F)Q@5)]H40>9GMFO,?&GBOR
M$:(/WQUKGC#4\3#T'4G8Y+QWXC_M"5H4?[K=JX0 OR:ENG,]R\Q.=QS3?N+F
MN^FK(^MPU%0@-"TF*<K<YI,\UI8ZT)1BC-&: "BC-&: "C%&:,T %&*,T9H
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M*DCR\?AE4B?4,9W@,*EKGO#.K#4+!'W9)KH:X)*S/E*D7&5F%%%%(S"BBB@
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M\>M?17BM]FC2D>E?-FO.9-28GUKJH;'T.3+1F<O3%'>DI:[%L?0ACFCO110
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M&5I^\AFQ7DDIZ#WKWCX96P_LF"3':N>L]#RLRG:FT>F#I2T#I17 ?)!1110
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MZC\,M3$2K"6ZM6==71Y694^>FSW!>E+34.4!]J=7GGR3"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0G H!R,T +7/>+K
MK[-HLKYQ@5T':O-OB1JZQZ;-;!OFQ5TU=G1A8\U5'BVM7)N[]I,YYJD/N4@)
M<%CZT=J]&*5C[:G&T4)3NU(*.]4:H**.]'>@044=Z.] !11WH[T %%'>@]:
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M3X3DQG\-GTGI7_(.A_W15VJ>E_\ (/A_W15RO-9\5+XF%%%%!(4444 %%%%
M!1110 5S'B_/]GR8_NFNGKFO%QQITG^Z:NG\1TX3^*CYENL_VC/_ +QIIJ2Y
M(&HS_P"\:97HQV/M*'P"449H%4:A11F@4 %%&:!0 449H% PHHHH *1NAI<T
M'[IH8NAZ-\,,[VQZU[Q#_J5^E>$?"XX=L^M>[Q?ZI?I7GUOB/D,S_BCZ***Q
M/,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK9S
M3J* (RF[K44EG'(,,O6K-%.[*4FMC$NM M90<QC\JX7Q+X35PWDQ]O2O5",U
M$]M%)]Y0:N-1HWI8F4#YCOO"%\DA(1L?2LN;1KBW.&!_*OI^\T>VDC8")<_2
MN*UCPD)BVR/]*Z*=734];#8Y->\>&-&8^#3"37H.H>")U)(0U@77AJ6 $%36
MOM$>K#%QDM&<Z#2=ZMRV#PGD&JS?*<5:DF;JJI;!SB@#/- .1BG+\JX-%S6+
MN-/!H-*3FDZ"F:!244O:FR0I*6EH&)24N:.U&X!11FCM0 449H[4 %%&:.U
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M5!;/OB4^U3UP-6/CFK.P4444A!1110 4444 ?'Q%!HHKUC]#"@T44 %!HHH
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M^6S6CRRYD;M%%%<YXP4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;307'X&S-,QQ2@]J6I8TAE. ^7-(>M':@304=J*#5 @[4=J2EI##M1VI*6@
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MT5\T-]Y/K7TMX"/_ !3EL/\ 9%<U8^?S?8ZZB@45QGSH4444 %%%% !1110
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MCX6X#MGUKW>+_5+]*\'^%XR[?6O>(?\ 5+]*\^M\1\AF?\0?1116)Y@4444
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M MA;:<B 8P*\5^'=CYNHPR8KWNWC\N(**XJTKGR^:U>:7*34445SGC!1110
M4444 %%%% !2'I2TAZ4 >3_%#_D'RUXI']VO:OB?_P >$IKQ:,_+7?1V/K<J
M_ACNU%'?-&:V1ZS"BBC-,04449H ***,T %%%% !24N>:3O28#'^\G^]7TOX
M"'_%-VW^Z*^:6^^GUKZ7\!?\BW;?[HKFK'S^;['6BBBBN,^="BBB@ HHHH *
M*** "BBB@ J*>,/&01VJ6@]*!IV9XE\0]$(#2HO5J\M9=C;#U%?2GBW2Q>63
M?+FOG;6;<VFI2J1C#5VT9'T^78B\+%8C*@"F'BE1N](WK72>RF(!FBA3BC/-
M),?46DH!YI:H>XE%%&>:0@HHHSS0 4449YH ***,T %%%&: "BBC- !111F@
M HHHH 0]*W_"/_(07_>%8/:M[PE_R$%_WJBIL<N,_A,^EM*_Y!T/^Z*NU2TK
M_D'0_P"Z*NUYKW/B9?$PHHHI$A1110 4444 %%%% !7,>+P?[/D_W373US/B
MXXT^3_=-73^(Z<)_%1\S70/]HS_[QI*?<G&HS_[QIE>C'8^TH? )10*,U1J%
M% HS0 44"C- !10** "B@49H *1ONTHIK=#0#V/2/A@"7./[U>\0_P"I7Z5X
M1\+CAV^M>[Q?ZI?I7GUOB/D,S_B#Z***Q/,"BBB@ HHHH **** "BBD)H 6J
M]Y,(+9Y#T J>N1\9ZVMC92Q;L$J:<5=FE*#G))'F?C_7#=76V-^.AKSACEB:
MO:A>M<W#DG/-417H4UI<^PPE'D@D**4T=!25L=P=J!UI0>*;4]1 XSR*LV%]
M-:SKM8@9J 4UN*4E=&=2FFCU[PMXI"(HD?\ 6O3]-U:.]C!4@U\NV-\]N1AB
M*]!\->,A9*J._?O7+4IGA8S!<VJ/=J*Y_0M?35(0P85O@@CK7,TUN>%.#@[,
M6BBBD0%%%% !1110 4444 %%%% !1110 4444 %%%% "5R/CQ]N@W'^[77=J
M\W^(^J+'I\UOGDK6M+XCHPD7*HK'A$K;YF/O0G6F)_%]:>#BNY(^VHQM!"N>
M:;0>:3/-6E8T'$9YIM/W?+BFYXI!>X8.,T4X'Y<4W-" **.U&>*8PHH[49XH
M **.U)0(7%;'A93_ &W']:Q^U;WA%=^MQ+[UG,YL2[1/HWP_QIR?2M:LS1$V
M6"#VK3KSY;GQ=;^(PHHHJ3(**** "BBB@#X^QBBBC->L?H08HHHS0 8HHHS0
M 8HHHS0 8Q11FBA +TI#2TE PQ2-TI<TAY% GL=AX&&+U/\ >%?1EI_QZQ_[
MM?.?@8YO4_WA7T9:?\>L?^[7#B-SY3-OC1-1117.>0%%%% !1110 4444 %%
M%% ',>+K$7&FS-C.%-?.6HV_D73KCO7U/JL/G6$JXZBOG/QM9&SU#A<9-=-&
M70][*:MDT<OC%% .:,UVH^CCJ@H-&:.M#*#%&*,T9H$&*,449H ,48HHS0 8
MHQ11VH&&*7'-%)F@3%(YI.G%+UYI.](%H&.<4I&UL4F>]+]X;J"96$<D# -;
M6B:T^FXRQX/K6,/F&:C89-9RA<PJ4E)'K>D?$$F182_7WKT#3-?2X"Y<<^]?
M,\$C6\RN">*Z6U\736H&&/%92I'DUL G=H^D4NT;'S"IA,F?O"O#-.\=S2("
MSFM^U\9,ZY+_ *UDZ3/.E@)GJWF+ZTN]?6O-D\79_CJZGBA3"3YGZU/LF9?4
M:AW9D7UH,J@?>%>>/XK 4GS/UJA<>,BJ'#T>R8U@:AZ:]RB_Q"LR]U=(%)#C
MCWKRF\\=2JC8<USEUXXGFR"QYJU2.FEE\NIW^M^._LC,@?\ 6O.]<\4-J>X!
MSS[UAW]\UZ2Y)JA&F%S6U.G8]7#8.--CF5CDDFE'W<4;OEH'W,UNK(])12 #
M/%+MP<4U3@TXGG-#+ CFCVI":7MFF-![4F***+##'-*.N*2@'!S28"D8.*/:
M@G)S24^@@Q1BC-%'D 8H[T49H .] &XXI^,KFFC@T= 8H7YL4C#<VP4;OFS5
M[1;4WNJ(F,Y-3)V1C6ERP;/7OAMI6RSAG*UZF.E<WX1L?L>D1KC&!72#I7GU
M'=GQF*GSU&Q:***S.8**** "BBB@ HHHH *0]*6D/2@#R?XH?\@^6O%8Q\N*
M]J^*'_(/DKQ6,_+7?0V/KLK_ (8_VI,4=LT5N>J&*,444>0@Q1BBBCR ,48H
MHH ,4444 &*2EI*3 :WWT^M?2O@(_P#%.6P_V17S4_WD_P!ZOI7P"/\ BF[8
M_P"R*YJQ\_F^QUXHH%%<9\Z%%%% !1110 4444 %%%% !1110!7NH1-"RD=1
M7@_Q!\/FUEDN OWF]*^@#TKC/&NC+?6)^7/>M:<[:'?@:W)42/G!1V/:GCYN
M/2K6IVS6E_(F, '%4UX.:[T[H^MIRYE<,<XH R:<?6DZ<TVK&W03'-+29HI@
M@HQ110 8HQ1FB@ HQ1FB@ HQ1FB@ HQ1FB@ HQ1FB@ HQ110 48HHH #TKH/
M""YU!?\ >%<\>E=!X0;&H+_O"LZGPG)C/X;/I;2_^0=#_NBKE4]+_P"0=#_N
MBKE>:SXJ7Q,****"0HHHH **** "BBB@ KF?%RYT^3_=-=-7,>+SC3Y/]TU=
M/XCIPG\5'S1<C.HS_P"\::>:=='&HS_[QIM>C'8^TH? )1BC-%4:A1BC-% !
M1BC-% !1BC-&: "C%%% !2$?*:7-(?NF@.AZ/\+EW.WUKWB'_5+]*\'^%YP[
M?[U>\0_ZE?I7GUOB/D,S_BCZ***Q/,"BBB@ HHHH **** "D-+2'I0!7N[@0
M6SR$_=%>$^/]?-U=; WMUKTSQEJXL[21 W537SUJEXUY=LQ.>:Z:5.^I[>68
M?WN=E<)DDT8I=V!BF%N:ZUIH?3122'4F** :M%!BE"Y&:*<O'%2P8SI2[=PS
M2N*16P,4-BZ!Y7&:$W*P8$\4X-36.#BBRZF4HH[+PWXP;2U$9<]?6O6?#OBE
M=1C!+C\Z^<=N'#>E=!HWB233BJACUK"I339Y&*P2FW)'T[%,CKD,*ER#7DV@
M^,FG50[UWNG:O%.H)<?G7+*FT>+5PDX:LW:*B6XC<<,*=NR:SL<EF/HHHH$%
M%%% !1110 4444 %%%% !2&EIKL%7)H 9+*$0DFO!OB;J6[56B#9!%>F>*M<
M6QM)"K\@5X#KNHMJE^9F.>:Z:,=;GN9;AGS<[,Q?6G8S28XI0:[+'TT=K 1Q
M1MXS2GKBC.!B@)(81S3L<4=Z7VH!(2C%+24QAVHQ1FB@0=J,49HH .U&*,T4
M;C$/2NE\#)YGB&'ZUS+=*Z_X>(6\10\=ZSJ/0X,<[4VSZ)L$V6RCVJW4<*[8
MU'M4E><]6?&S=Y-A1112)"BBB@ HHHH ^/C1117K'Z&!HHHH #1110(#0:**
M "BBBA +2&E%)0,*&Z44C=*-Q=#L/ __ !^Q_P"\*^C+3_CUC_W:^<O O_'Z
MF?[PKZ-M/^/6/_=K@KK4^5S;XT34445@>.%%%% !1110 4444 %%%% #74.A
M4]Z\>^)6BEI?-1> ,U[%7/>*].2[T>X)7+;3BK@[,Z<)6=.:9\P8P[#T-&*L
MWUH]G=2*XQECBH$^X<UZ,7='VE*=X(;0>*%Z4$&G?4T3T"CO2 8IW:F-:B4=
MZ4=*2A#84=Z**!!2TVE[4KC%'6E?K310>:!"KUI7 !IHH-, %/. M,H- FK@
MAI2.]-%.[4#2TL)C)H\L%L444-$\J)%D,)PO2K":G)'P":IGFFD<5/*2Z:-+
M^VI@>":D'B"X"XW&LG;Q2A1MI<IC[%,T3KLY.,FF-JLKC!)JALXH"TE$<**N
M3O<-(<$]:@:,;LTN*6JY3=02!!SBG\!L4P49.:=AV0K@9XIHZXI>M&* :!A@
MT=J**:V&M!.]/IM+VH0T'>CO244VQ"C[U#CYN*2BHL "@T4=:H %'>C&*7M1
MYC0G>CO244 .4_/BG8&^F#KFG4;(FPDF :[CX>Z2USJT,I7Y3WKB%B:=@B_>
M)KWSX;Z.L&CPRNOSUA5G[IY>9U_9PY3O+:!8(51>@J>D'2EK@/DV[A1110(*
M*** "BBB@ HHHH *0]*6D/2@#R;XG_\ 'A+7BT?2O:OBA_R#Y*\4C^[7?1V/
MK<J_AC^]'>CM16R/68=Z.]%%,0=Z.]%% !WH[T44 '>CO110 =Z**2@!K_?3
MZU]+^ O^1;MO]T5\T/\ >3ZU]+> C_Q3=M_NBN6N?/YOLCKJ*0=*6N,^="BB
MB@ HHHH **** "BBB@ HHHH *JWUN+B!E([5:I&&1BFAQ=G='SYX\T8VT\DJ
MKC+5P@'&#7T!X^T875AE%RW7I7@MW$;>\>-N,&NVC*Z/J\NK\\+$/>D;I2=Z
M&&1Q71<]:^@J#)H[T@XHI6L"#O110>E,:#O1110(.]%%% !10>E)2N,6BBBF
M(**** "BBB@ HHHH .U;WA'_ )""_P"]6#VK?\(C.H+_ +PJ*FQRXS^$SZ5T
MK_D'0_[HJ[5+2O\ D'0_[HJ[7FO<^)E\3"BBBD2%%%% !1110 4444 %<UXN
M _L^3_=-=+7,>+\_V?)C^Z:NG\1TX3^*CYIN0/[0G_WC3*6ZS_:,_P#O&FFO
M1CL?:4/@"@4451L% HHH$% HHH ***2@!11110Q@*1ONFEI&Z&C9">QZ1\+0
M"[9]:]WB_P!4OTKP?X89WG'K7O$/^I7Z5Y];XCY#,_X@^BBBL3S HHHH ***
M* "BBB@ J"[F$-N[DXP*G-<IXOUF.RT^5-V&*G%5&-V:4H.<DCS3Q]K@FG*(
MV1TKS7 ))-6M1O9;N[=F.1FJQ!QQ7H07*C['"4N2"0VDQ2]*,9K0[1R@;331
M1S24@'4Y<8S3*.:; D'(YIF!2 FCO2L-#P!MIAY-+FFT+036HX=*85 ;-.HH
M:"R:L6[;4Y;7[I-=7H_BN=$^9S^=<.5YIZR-&?EK.<+HXJV'4M#V_1/%8?;Y
MDG?UKMK37;211^\&:^9$U2XA^XQK6T[Q-=I*NZ0XSZU@Z6AY=?+KK0^F(KN*
M8?*V:L9KRGP_XPB5%\V0?G78P^+;*0#$@_.L94VCR:V%E3=CI:*R(=>MIONL
M/SJ['>1R#(-19G/R2[%JBF"0$9I0X-%B;,=13=PHWC%*P68ZBH6G51R:HW.L
MP6^=S 8]Z=F4H29HR2K&N6-86L:[;V]H^)!N ]:QM9\76P@<)(,X]:\?\1>)
M;F:Z8)(=I]ZVC2NKG?AL#*IJR]XK\0/=.Z!LJ?>N*7E23UI[SO.<N>:CZ5TQ
MC8^IH45"(\ ;*91VI*V-T.%!I!0:"N@HH-(*.]##H+VI.U!H% @[4=J4TE !
MVH[4#K1WI7 .U)2FDIB8-]RO0?AO:9U2&7'>O/7X2O8_AC8[K:&?%8U7:)Y>
M:3M3L>OK]P?2EI!T%+7GGR(4444 %%%% !1110!\?&B@T8KUC]# T448H #1
M11B@ -&:*,4 !HHQ10A"TAI>E)0,*1J6D;BAB>QV'@<YO8_]X5]&6G_'K'_N
MU\Y>!AB]C_WA7T;:?\>L?^[7#B'J?*9M\:)J***YSR HHHH **** "BBB@ H
MHHH *K7L0FM70CJ*L&D(R*:'%VE<^?/'^C&"]WHN!UK@\]17OOCS21<022!>
MBUX-<1&&=E/K7=1E<^MR^M[2.I%_%3V(R*:.32L,&MF>G8":.M)BE'%!20M)
M0?2DZ4(; T48HQ3)#O1GFBC% PH[T48H .]'>BC% !1WHHQ0 4=Z*,4 %'>B
MC% !WH[T48H *7-)1B@!:3O11B@ [T=Z*,4 '>CO11B@ [T=Z*,4 '>CO11B
M@ [T=Z*,4 '>CO11B@ [T=Z,48H .]*I^:DQ10(<W7-)WH]J3MB@8=Z#12]J
M.H"*?FI2P#4T#YJ5T.,TF]#-NVIO>%K+[9J\8QD$U]&Z!:"UTY$ Q@5Y%\.=
M&+RPW!6O;H$\N,+7#6E=V/F,UK<TK$M%%%8'CA1110 4444 %%%% !1110 4
MAZ4M(>E 'E'Q0_Y!\E>*1]*]J^*'-A**\5C'RXKOH;'UV5_PQ])WH]J*V1ZH
M=Z.]&**8!WH[T8HH .]'>C%% !WH[T8HH .]'>C%)28AK_?3ZU]*^ ?^1=MO
M]T5\TO\ >3_>KZ7\!#_BF[;_ '17-6/G\WV.NHH%%<9\Z%%%% !1110 4444
M %%%% !1110 4444 4]0MEN+=E9<\5\[>,]%>RU":;:0I;BOI1AD$5YSX_T$
M7=H65.<YZ5M2E9GI9=6Y*ECP5:>HQR:==1&"[>(C[IIK'Y17:GI<^NC)20P]
M:!2J,TAX.*T*#O1FCK24@%I12=:44#0AH%*1FC'%%PL(:!1UHH **,44 %%&
M** "BC%% !11BB@0AZ5T7@\@:@O^\*Y[&16]X1_Y""_[PK.IL<F,_AL^E]+_
M .0?#_NBKE4M*_Y!T/\ NBKM><SXJ7Q,****1(4444 %%%% !1110 5S7BX@
M:=)_N&NEKF/%XSI\G^Z:NG\1TX3^*CYIN2!J,_\ O&F4ZZ&=1G_WC3:]&.Q]
MI0^ 2@48HJC8*!1BB@ H%&** "@48HH$%%%% PH/W31C-(WW:!/8](^%Q =L
M^M>[Q?ZI?I7@_P +QN=OK7O$/^J7Z5Y]?XCY#,_X@^BBBL3S HHHH **** "
MBBD/2@"O>7 MX&<GH*\+^(FO&XNPD;\=#7I?C'6!9VDB;L$K7S[JMRU[=LQ.
M>:Z:4>I[66X:[YF4L]2>IJ1&&TYJ-EQBDKK1]-!60K]:<APM&,C--JK%/5A1
MTHQ2T=1C:7M1BB@09H[48HH&&:.U&** "CM1BB@ HHQ10(7(QBF9(/%.VY&:
M0#G-2U<AQN+]LN8CA7(K1L]8NHQ\TK?G6<0"<TA]JGD3,)X=2>IW&F>*'BQO
MD_6NNL?'$,: ,X_.O&,OV)I/,FSPY_.HE2.6> BSWU?']L$P7'YU8M_'=LZ_
M?'YU\]F6?^^WYU9M[N:-.7;\Z7L3G>61/H$^-K;^\/SJ)_'5LBX+C\Z\+&HR
M]=Y_.H9KR:3D2'\ZGV1*RR)[3<^/+<@@./SKD=<\6^>K>7)U'K7G1>8\[V_.
MDS(W5B::AJ=-/ *)<NM5N9I3^\;!JJ69S\QR:18\\FE_BS6Z2.RG2Y!>E!I3
MR,TVJ2.E/0.U':C%% PSQ1VHQ10 9XH[48HH ,\4HI,44 *:3M0:*$#89XH[
M48HH07"DI>V:,<4,0C?.-H]:^@_A?;!/#L;$<UX+IMN;G4%CQG)KZ1\#6OV7
M0XTQBN2N]#P<XE[AU%%%%<A\V%%%% !1110 4444 ?'V:*,4&O61^AAFBC%!
MH0!FBC%!H ,T48H- !FB@BBA"%ZTAI>E(:!@*1N12TC4=!/8Z_P,<WL?^\*^
MC;3_ (]8_P#=KYS\#C%['_O"OHRT_P"/6/\ W:X:ZU/E,V^-$U%%%<YY 444
M4 %%%% !1110 4444 )UH/2EHH!&/K=H+JQE&,Y%?.GBZQ-C?D;<9-?3\D8>
M,J>]>.?$?0LS&14S@5M1E9GK9=B.67*>2(>].8Y-*4\MF!XQ3:[]SZJ#NKB]
M>:3-+T%(.M-%L,T=>:5A2"D),7KS24ZF]Z:&PHS0:*!!FBC'-% PS11CFB@
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MS1VHQ0 49H[48H **.U/ !6@0@;"XIM%. &W-&P#>U)3P!MI0!MS0%Q@H-/
M&W-,- 7"C&:2I% VYHN PC'%(#CBE)YI,<T6)L.#87%)FC'%."C;FE8H W&*
M:>M%.QE<T/0!,\8IM+CBC'%&H6"C-':C%,849H[48H *,T=J,4 %&:.U+CC-
M#%>PE)2T[ VYH8"#I2?Q8I>U.P-N: EL-/I29QQ2^],?IFDP;LCH/!MM]H\0
M1+C()KZ1TF'[-:K'[5X;\.; OJ<,V.]>_P *81?I7#5=V?)YG5O/E):***P/
M)"BBB@ HHHH **** /CZB@T&O6/T,**#0: "B@T&@ I*4T&@ HHH-"$%%!H-
M !33TIU(]#$]CK_ O_'ZF?[PKZ-M/^/6/_=KYS\#_P#'['_O"OHRT_X]8_\
M=KAKO4^6S;XT34445SGCA1110 4444 %%%% !1110 4444 (>E8'B32DO=/E
M8KEMO%=!4<L8DC*GH::=BX2<7='RUXATZ2RO&&W S6,M>Q?$+0 7:6-. ,]*
M\@=/*D*GL:[Z4KGUV"KJ<$QIS2#-/QGF@C(R*VN=]]1IYI1TI :=06D)VH'2
MD[T4 %%+2=Z L%%'>CO0 44=Z.] !11WH[T %%'>CO0 44=Z.] !11WH[T %
M%'>CO0 44=Z.] !11WH[T %%'>CO0 44=Z.] !11WH[T %%'>CO0 44=Z.]
M!11WH[T %)2]Z#0(!0:%^]3F^]4W ;VIO(-/ ^:D8@-3N34=BS86SW5RL8&<
MFO>_ FAK:Z=%*RX<5YKX$T1KG48IF7*9]*]\L+9+:W5%& !7+6GI8^:S+$._
M*BT.E+117(>(%%%% !1110 4444 %%%% !1110 4AZ4M(>E 'D_Q0_Y!\E>*
M1_=KVKXG_P#'A+7BT?2N^CL?6Y7_  QW:BCO1WK9'K,**.]'>F(**.]'>@ H
MH[T=Z "BCO1WH *2E[TG>DP&2?>3_>KZ7\!#_BF[8_[(KYI;[Z?6OI?P%_R+
M=M_NBN:L?/YOL=8.E+117&?.A1110 4444 %%%% !1110 4444 %%%% !111
M0!B^(;$7EFRD9XKYR\2:=)8ZE,Q7"EN*^I)(Q(A!KR3XE:!OM?,A3YLY.!6]
M&70];+<1RRY6>.*<\T=Z-IAE,;=13L8YKN3/J8RNKC:6DSS13-$!I,D4X4AH
ML)@,FBG)CO2=Z2!"44M)3 **** "BBB@ HHHH **** $/2N@\(G&H+_O"L#M
M6]X1_P"0@O\ O5G4V.7&?PF?2VE?\@Z'_=%7:I:5_P @Z'_=%7:\Y[GQ,OB8
M4444B0HHHH **** "BBB@ KF/%^?[/D_W373US7B[']G29_NFKI_$=.$_BH^
M9;K/]HS_ .\:0T^YQ_:,_P#O&F5Z,=C[2A\ E% H%4;!10*!0(**!0*!A10*
M*!!10** "D/W:44C?=- /8]'^&&?,;']ZO>(?]2OTKPCX6XWMGUKW>+_ %2_
M2O/K?$?(9G_$'T445B>8%%%% !112$XH KWDZPP,Q.,"O#_B!KS23^7&V5/!
MYKTOQAJRV=G(N[!*U\^:K>-=W+ECGFNJC#2Y[66X>[YF9G\9/J:?O(&!2 4X
M8Q77;0^E2LA**5>!S13N5%W#..E)11VH*"BEHH 2BG#I3:"0HH[4=J"@HH[4
M=J "BCM1VH *4'BD[44 !HR0*44&AA80&E)[44G:E8+!DXI*7M1VIBL)2C.:
M.U.&-M)@T-/6A>M)2]J.@#GZTW)QBCK2]J?0!*49Q1VIPQLI@,-%+VI.U)#"
MBCM1VH **.U':@ HH[4=J "C-':BBPF)2@]J7M2=J0[ :7/&*3M15(3"A5W,
M%I015G3XC/?*@[FHF[(BI)*)Z]\-].VVT4NVO6%& *Y'P-8BWTB/(YKKZ\ZH
M[L^*QD^:JPHHHJ#E"BBB@ HHHH **** /C[%%!-&:]8_0@Q10:,T &**#1F@
M Q10:,T &**,YHH0!12]:2@88I&Z4M(W- GL=?X%&+U/]X5]&VG_ !ZQ_P"[
M7SGX&.;U/]X5]&6G_'K'_NUPXC<^4S;XT34445SGD!1110 4444 %%%% !11
M10 4444 %%%% &'XATY;RQE7;DE:^>/$^D/IUX001DU]02*'0@BO+_'_ (<^
MT[IU3[HKHI3Z'J9?B.67*SQ)3\N*4':I!I]U"8)BI&,&HL[B*[(L^IC+F5T(
M*<.E##;2*:HU6@&DI310 H'%)2YXI.M)%,***,TR0HHHS0 4449H ***,T %
M%%&: "BBC- !111FCR **,T9H\@"BC-&:/(8449HS1Y %%%&: "BBC- !11F
MC/- !111GF@ HHSS1GF@ HHSS2^] #:<*/>D[TK!L+NQ4^GV;:A>K$@Y)JL5
M+'BO2/A_X;,MS#=,O%9SE9'#C*ZA%GH'@?0A8Z;'O3YA7<J,#%06L"PPA0,8
MJQ7#.5V?(5JCG*X4445!B%%%% !1110 4444 %%%% !1110 4AZ4M(>E 'D_
MQ0_Y!\E>*1CY:]K^*'_(/DKQ6,_+7?0V/KLK_AC^U)2^])6YZH449HH$%%&:
M,T %%&:,T %%&:* "DI<TG>DP&M]Y/K7TMX"/_%.6P_V17S2_#)]:^E? /\
MR+EL?]D5S5CY_-]CKQ1117&?.A1110 4444 %%%% !1110 4444 %%%% !11
M10 5B^(-/6]LV4KGBMJF2J&C8'N*<79W+IS<)*2/EGQ+I;6.I3-C W5D9W(
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MVHIZ!82BBE[4:"$ I:,\49XH&%!I,T9XI7 **2ESQ2;$%&*,T4]QA11FBC<
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MHHH .]'>BB@ [T=Z** #O1WHHH .]'>BB@ [T=Z** #O1WHH/% KAWH[T4E
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MIL<F,_AL^E]+_P"0?#_NBKE4M*_Y!T/^Z*NUYK/BI?$PHHHH)"BBB@ HHHH
M**** "N:\78_LZ3/]PUTM<QXOS_9\G^Z:NG\1TX3^*CYIN<?VC/_ +QIE+=
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MHJP:;'(ZX8>U=^!5#2K1;6T5%&.*T*\^;NSXW$3YZC84445!B%%%% !1110
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M5'S1<G_B83_[QJ/-.NQ_Q,9_]XTBKD5Z$7H?9T'[HF:,T8H JC<,T9HQ0!0
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M%73K-%"XQ724R- B@"GUQRE=GRM2;G*["BBBI,PHHHH **** "BBB@ HHHH
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M](^%XW.WUKWB'_4K]*\(^%IPS?6O=8S^[7Z5PUM6?)9FOWA+1116!Y@4444
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M8\!?\BW;?[HKYJ>WDWIQWKZ3\!!E\.VP/]T5S5M3P<U=T=?10**XSY\****
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M HHHH **** "BBB@ HHHH **** "BBB@#P0^$I<C]V?RI7\)2X'[L_E7M?\
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F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140074490957120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 31,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IONIS PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000874015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0336973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2855 Gazelle Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Carlsbad<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">931-9200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.001 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IONS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>brhc10043749_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ions-20221031.xsd" xlink:type="simple"/>
    <context id="c20221031to20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874015</identifier>
        </entity>
        <period>
            <startDate>2022-10-31</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20221031to20221031"
      id="Fact_01e560f1345d40fba67a31034b222d5b">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20221031to20221031"
      id="Fact_f3ed2dd34fe54c06ad2f43805391a9f8">0000874015</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20221031to20221031"
      id="Fact_790431b79ccc47fea740d159fc445680">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20221031to20221031"
      id="Fact_47a3f15131ba4fac910ebdb6c55dd91f">2022-10-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20221031to20221031"
      id="Fact_c43555badf0f4e20881bd9385862ce9c">IONIS PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20221031to20221031"
      id="Fact_4f88943a0af1451cbba0a92f7e9d9367">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20221031to20221031"
      id="Fact_2cc4a9dc8fea4690910a3f596d4ee0f7">000-19125</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20221031to20221031"
      id="Fact_89dfd0513734463ba9a4279faaa6665c">33-0336973</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20221031to20221031"
      id="Fact_be5f9465d77a435b916c3523d1debc0e">2855 Gazelle Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20221031to20221031"
      id="Fact_4213a772edbb4560aceeb756dd026a12">Carlsbad</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20221031to20221031"
      id="Fact_fb93b2adf4b340e7a4c61b1c6d9f5596">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20221031to20221031"
      id="Fact_da505f5509b64be2b3e03832efaef66f">92010</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20221031to20221031"
      id="Fact_59bc6e9f18174394b19040d4d4e4842c">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20221031to20221031"
      id="Fact_b86d1417f95a49de83a85a49858efa80">931-9200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20221031to20221031"
      id="Fact_2afe8610d52e48b7bb9e0dcd8699af8f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20221031to20221031"
      id="Fact_4666e54c0a154c6697edecf3d90084ab">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20221031to20221031"
      id="Fact_df8d8a703f59473f98845cbe45a4ec88">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20221031to20221031"
      id="Fact_7d8f91dc0d894fedbd62f9fb3e11844a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20221031to20221031"
      id="Fact_585c20a6736044a4b0e959d3d7c3ce51">Common Stock, $.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221031to20221031"
      id="Fact_fb402b1fa5a44b36b1228583b6337863">IONS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20221031to20221031"
      id="Fact_e4b4eff21c7740b4b094c9d33f090723">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20221031to20221031"
      id="Fact_c8f29498c1894557b6d05ef4f9fd8e61">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4K<$%[?M]S21F]=H0[,U.]I06X0>_/#:_P-;NM8]P#NI!]RD3*Y-ECZ @MY
MQ:<YS1HGM$6P;:'FU>;OX4[]%7*E6698TB+;MR;5B(0+M2(=K/1Q6PY%PB.N
M3:+NP4,EIXT%U:+2RE,[NX>[\%RR\PC2P\#$=TM\6&7#9N1QM6HVB1:]5K+:
MV#W<AG\@FRE5 %DKX/_<!M@'&TRS6;^GIIX52=@*A)R+ 5BUW.U_=P,M\G+/
MN10:=K#EX8918#,WP/65$/I]8+:QU7\AIO\"4$L#!!0    ( *LX9%6?H!OP
ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ JSAD59E<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" "K.&15UTLIG5,$  "1$   &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ JSAD59^@&_"Q @  X@P   T
M             ( !E@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "K.&15
MEXJ[',     3 @  "P              @ %R#P  7W)E;',O+G)E;'-02P$"
M% ,4    " "K.&15'#AEZC\!   \ @  #P              @ %;$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ JSAD520>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ JSAD5660>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10043749_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ionispharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10043749_8k.htm">brhc10043749_8k.htm</File>
    <File>brhc10043749_ex99-1.htm</File>
    <File>ions-20221031.xsd</File>
    <File>ions-20221031_lab.xml</File>
    <File>ions-20221031_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10043749_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10043749_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ions-20221031_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ions-20221031_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ions-20221031.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ions",
   "nsuri": "http://ionispharma.com/20221031",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10043749_8k.htm",
      "contextRef": "c20221031to20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://ionispharma.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10043749_8k.htm",
      "contextRef": "c20221031to20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-22-039934-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-039934-xbrl.zip
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MF-JX)K4KV>*#E(Z1UE;UIN2UAK2UM?'M(WOOOL%>4SX&""\2<#$JDH;0J3"
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MR'8%ZC7(3@I*H!ZRY";-M-76P@HYZ:\%RV\Y@/T:%SDKG774;:M&QA,-"R8
M5&)>*&+M@M0S,SHONG"3J<E=8:&]?"QR U52,PFJTGY&O->)0IAX\X-ZF"G'
M"P],Y<_P$V"C(NH!/TS !G1.;HY L"J#N1#=N<E[?&FC^<WSJ\M_;C6WLME&
M._ J=>-X+>II48W9]_I[WY(I<Z81+#%.]1(U@U!4D=(>7 GC:_)^B@?X($<
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M?G_%\6OZ-1W\(OPRDO\'4$L#!!0    ( *LX9%4L9XPA2 ,  $,/   1
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MCU7KIOF@KUTMK6W(URY7F54Y[F"52]TT'_0MIB%97,2+]@>N=N5J\/>I3SM
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M>G;7G8IW.);6XHI]XF_^+9K"_$VYL_\!4$L#!!0    ( *LX9%7T1'4_W04
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M?U!+ 0(4 Q0    ( *LX9%6):@K+@A0  "EY   3              "  0
M  !B<FAC,3 P-#,W-#E?.&LN:'1M4$L! A0#%     @ JSAD5<E%'FAK$
ME40  !<              ( !LQ0  &)R:&,Q,# T,S<T.5]E>#DY+3$N:'1M
M4$L! A0#%     @ JSAD52QGC"%( P  0P\  !$              ( !4R4
M &EO;G,M,C R,C$P,S$N>'-D4$L! A0#%     @ JSAD5<<K+3* "   =5@
M !4              ( !RB@  &EO;G,M,C R,C$P,S%?;&%B+GAM;%!+ 0(4
M Q0    ( *LX9%7T1'4_W04  /@^   5              "  7TQ  !I;VYS
G+3(P,C(Q,#,Q7W!R92YX;6Q02P4&      4 !0!+ 0  C3<

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
